Healthcare pays modest yields but combines defensive demand with strong free cash flow, which is the combination that funds decades of raises. Patent cliffs, not recessions, are what threaten these dividends.
63 operating companies currently paying a dividend, median yield 1.23%. Funds and ETFs are excluded on purpose — this is companies only. Prices as of Sep 3, 2026.
No company in this sector pays monthly — the quarterly cheque is the norm here. For monthly income, look at REITs, BDCs and specialty finance.
Specialty finance63 shown · click any column to sort
| Company | Industry | Yield | Annual $ | Payout | Div growth | Streak | Quality | Size | 1Y |
|---|---|---|---|---|---|---|---|---|---|
LLYraised Eli Lilly and Company | Pharmaceuticals | 0.60% | $6.92 | 22% | +15.2% | 11y | 84 | $1.03T | +54.7% |
Johnson & Johnson | Pharmaceuticals | 1.93% | $5.36 | 61% | +5.3% | 64y | 70 | $645.9B | +54.0% |
AbbVie Inc. | Pharmaceuticals | 2.66% | $6.92 | 190% | +6.8% | 54y | 48 | $451.5B | +20.4% |
Merck & Company, Inc. | Pharmaceuticals | 2.23% | $3.40 | 269% | +5.8% | 14y | 49 | $366.0B | +78.9% |
UnitedHealth Group Incorporated | Managed Care | 2.34% | $9.28 | 58% | +12.6% | 15y | 85 | $359.9B | +27.9% |
Novartis AG | General Drug Manufacturers | 2.25% | $3.70 | 70% | +3.5% | 24y | 21 | $301.3B | +36.7% |
AZNcut AstraZeneca PLC | General Drug Manufacturers | 0.96% | $1.59 | 47% | +2.3% | — | 24 | $252.3B | -0.5% |
Amgen Inc. | Biotechnology | 2.27% | $10.08 | 61% | +8.3% | 14y | 60 | $233.8B | +56.1% |
Abbott Laboratories | Pharmaceuticals | 2.32% | $2.52 | 79% | +10.4% | 54y | 33 | $191.2B | -18.4% |
Gilead Sciences, Inc. | Biotechnology | 2.17% | $3.28 | 43% | +3.0% | 10y | 79 | $180.6B | +33.9% |
Pfizer, Inc. | Pharmaceuticals | 5.97% | $1.72 | 226% | +2.5% | 16y | 35 | $159.4B | +15.9% |
DHRraised Danaher Corporation | Industrial Instruments for Measurement, Display, and Control | 0.77% | $1.60 | 26% | +12.2% | 13y | 71 | $146.0B | +4.3% |
Bristol-Myers Squibb Company | Pharmaceuticals | 3.70% | $2.52 | 55% | +1.6% | 17y | 70 | $138.2B | +43.1% |
CVS Health Corporation | Drug Stores and Proprietary Stores | 2.75% | $2.66 | 70% | +5.9% | 9y | 64 | $123.7B | +31.3% |
Medtronic PLC. | Electromedical & Electrotherapeutic Apparatus | 3.09% | $2.88 | 76% | +4.4% | 49y | 62 | $116.8B | +1.4% |
Stryker Corporation | Medical Devices | 1.16% | $3.52 | 36% | +7.6% | 33y | 72 | $116.3B | -23.1% |
HCA Healthcare, Inc. | General Medical & Surgical Hospitals | 0.76% | $3.12 | 10% | +46.3% | — | 35 | $90.5B | -1.6% |
Regeneron Pharmaceuticals, Inc. | Pharmaceuticals | 0.45% | $3.76 | 9% | +40.1%† | 1y | 55 | $85.2B | +45.9% |
Elevance Health, Inc. | Managed Care | 1.66% | $6.88 | 30% | +12.5% | 14y | 85 | $85.1B | +32.3% |
The Cigna Group | Managed Care | 2.21% | $6.24 | 25% | +172.8% | 13y | 79 | $74.7B | -7.1% |
Cencora, Inc. | Drug Distribution | 0.71% | $2.40 | 17% | +5.8% | 16y | 73 | $61.5B | +13.1% |
Cardinal Health, Inc. | Drug Distribution | 0.83% | $2.06 | 28% | +0.9% | 29y | 76 | $54.6B | +65.5% |
Becton, Dickinson and Company | Medical Devices | 2.24% | $4.20 | 73% | +5.4% | 54y | 39 | $51.1B | -3.4% |
Humana Inc. | Managed Care | 0.87% | $3.54 | 34% | +7.2% | — | 27 | $46.3B | +28.7% |
Agilent Technologies, Inc. | Laboratory Analytical Instruments | 0.68% | $1.02 | 20% | +6.6% | 11y | 74 | $42.5B | +17.4% |
Alcon Inc. | Medical Instruments & Supplies | 0.40% | $0.28 | 27% | +11.9%* | 4y | 21 | $34.1B | -10.7% |
RMDraised ResMed Inc. | Medical Devices | 1.15% | $2.64 | 23% | +7.7% | 13y | 66 | $33.4B | -16.6% |
Zoetis Inc. | Pharmaceuticals | 2.78% | $2.12 | 33% | +20.1% | 13y | 42 | $31.5B | -50.5% |
GE HealthCare Technologies Inc. Common Stock | X-ray Apparatus & Tubes & Related Irradiation Apparatus | 0.20% | $0.14 | 3% | +3.7%† | 2y | 21 | $31.1B | -7.1% |
Royalty Pharma plc Class A Ordinary Shares | Pharmaceuticals | 1.47% | $0.94 | 49% | +24.0% | 6y | 78 | $28.1B | +73.3% |
Labcorp Holdings Inc. | Medical Laboratories | 0.87% | $2.88 | 24% | +10.1%* | 2y | 51 | $26.9B | +18.8% |
Quest Diagnostics Incorporated | Medical Laboratories | 1.44% | $3.44 | 26% | +7.3% | 14y | 67 | $26.6B | +31.7% |
West Pharmaceutical Services, Inc. | Medical Devices | 0.26% | $0.88 | 11% | +5.5% | 25y | 81 | $24.1B | +37.3% |
STERIS PLC (Ireland) | Orthopedic, Prosthetic & Surgical Appliances & Supplies | 1.23% | $2.76 | 31% | +9.3% | 21y | 71 | $21.9B | -7.7% |
Viatris Inc. | Pharmaceuticals | 2.83% | $0.48 | 960% | 0.0%* | 1y | 3 | $19.6B | +63.4% |
Zimmer Biomet Holdings, Inc. | Orthopedic, Prosthetic & Surgical Appliances & Supplies | 0.97% | $0.96 | 23% | 0.0% | 14y | 57 | $19.2B | -6.4% |
Revvity, Inc. | Laboratory Analytical Instruments | 0.22% | $0.28 | 14% | 0.0% | — | 61 | $14.5B | +52.0% |
BAXcut Baxter International Inc. | Medical Devices | 0.16% | $0.04 | 308% | -11.4% | 0y | 40 | $13.2B | +9.5% |
Encompass Health Corporation Common Stock | Hospitals | 0.69% | $0.84 | 13% | +11.8%† | — | 21 | $12.0B | -2.2% |
Bio-Techne Corporation | Biotechnology | 3.59% | $2.60 | 28% | — | 4y | 64 | $11.3B | +36.9% |
Universal Health Services, Inc. | General Medical & Surgical Hospitals | 0.47% | $0.80 | 3% | +31.9% | — | 65 | $10.1B | -8.6% |
The Ensign Group, Inc. | Skilled Nursing Care Facilities | 0.15% | $0.26 | 4% | +4.5% | 19y | 73 | $10.1B | -1.3% |
Bruker Corporation | Laboratory Analytical Instruments | 0.34% | $0.20 | 39% | +4.6% | 1y | 27 | $8.5B | +96.4% |
AptarGroup, Inc. | Plastics | 1.51% | $1.92 | 34% | +4.9% | 32y | 73 | $8.2B | -8.0% |
CHEraised Chemed Corporation | Home Health Care Services | 0.54% | $2.80 | 12% | +10.8% | 17y | 72 | $6.8B | +13.1% |
Teleflex Incorporated | Medical Devices | 0.97% | $1.36 | 23% | 0.0% | — | 53 | $6.0B | +7.2% |
Stevanato Group S.p.A. | Medical Instruments & Supplies | 0.26% | $0.05 | 11% | +1.9%* | — | 21 | $5.6B | -11.0% |
Concentra Group Holdings Parent, Inc. | Specialty Outpatient Facilities | 0.73% | $0.25 | 16% | 0.0%† | 1y | 61 | $4.4B | +46.4% |
Organon & Co. | Pharmaceuticals | 0.58% | $0.08 | 10% | -32.8%* | — | 64 | $3.6B | +42.4% |
NHCREIT National HealthCare Corporation | Skilled Nursing Care Facilities | 1.23% | $2.68 | 29% | +4.0% | 10y | 64 | $3.4B | +89.9% |
DENTSPLY SIRONA Inc. | Dental Equipment & Supplies | 6.20% | $0.64 | 29% | +9.9% | 12y | 56 | $2.3B | -20.6% |
Select Medical Holdings Corporation | Hospitals | 1.51% | $0.25 | 23% | -20.6%* | — | 27 | $2.0B | +11.2% |
Perrigo Company PLC | Pharmaceuticals | 7.77% | $1.16 | 110% | +5.2% | 23y | 23 | $2.0B | -35.9% |
LMATraised LeMaitre Vascular, Inc. | Medical Devices | 1.24% | $1.00 | 32% | +16.1% | 14y | 74 | $1.8B | -16.9% |
Phibro Animal Health Corporation | Pharmaceuticals | 1.25% | $0.48 | 20% | 0.0% | 3y | 21 | $1.6B | -2.1% |
U.S. Physical Therapy, Inc. | Health Services | 2.32% | $1.84 | 11% | +41.3% | — | 75 | $1.2B | -7.5% |
IRMDcut IRadimed Corporation | Medical Devices | 0.96% | $0.80 | 41% | +5.7%* | — | 48 | $1.1B | +15.7% |
HSTMraised HealthStream, Inc. | IT Services | 0.48% | $0.14 | 18% | +12.4%† | — | 61 | $870M | +3.5% |
KMDAcut Kamada Ltd. | Specialty & Generic Drug Manufacturers | 1.99% | $0.17 | 66% | — | 1y | 18 | $493M | +21.0% |
EMBCcut Embecta Corp. | Medical Devices | 0.69% | $0.04 | 31% | +26.0%* | — | 61 | $322M | -60.0% |
Utah Medical Products, Inc. | Medical Devices | 1.75% | $1.24 | 38% | +1.7% | — | 60 | $228M | +13.3% |
Spok Holdings, Inc. | Wireless Telecom | 11.67% | $1.25 | 219% | +20.1% | — | 36 | $224M | -40.9% |
Esperion Therapeutics, Inc. Common Stock | — | — | — | — | — | — | — | — | — |
Operating companies only — ETFs, closed-end funds, ADRs and preferred shares or baby bonds are excluded. Payout ratio and raise-streak data isn't published for every company; blanks mean we don't have it rather than zero. * marks a 3-year growth rate where 5 years isn't available; † marks a 12-month growth rate shown because the longer rate is distorted by a stock split.
We currently track 63 healthcare operating companies paying a dividend, with a median yield of 1.23%. ETFs, closed-end funds and ADRs are excluded from this count — those are funds, not companies.
SPOK shows the highest trailing yield in the sector at 11.67%. Treat the very top of any yield list with suspicion: an unusually high figure is often a special or one-off payment sitting in the trailing rate, or a share price that has collapsed.
Yield alone tells you nothing about safety. In this sector 47 of 63 companies pay out 60% or less of earnings, which is the group with genuine room to keep raising. 5 have cut their dividend recently, and 6 have raised.
No. Every dividend payer in this sector pays quarterly, semi-annually or annually. Monthly dividends are concentrated in REITs, BDCs and specialty finance.
Nightly. Prices, yields, payout ratios and performance come from our own data pipeline, and this page reflects prices as of Sep 3, 2026. New dividend initiations and cuts are picked up automatically.
Disclaimer: The information provided on this website/service is for informational purposes only and does not constitute financial, investment, or legal advice. Investing in stocks involves high risk, including the loss of principal. We are not responsible for any financial losses or damages resulting from your reliance on this data. Always consult with a qualified financial professional before making investment decisions.
Trademark Notice: Twylight Crow's Dividend Tracker (formerly indexed as DiviDrip) is an independent portfolio utility. This tool is not affiliated with, authorized, endorsed by, or in any way officially connected to Dividrip.com or its international affiliates.